Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

muscle-invasive bladder cancer

Oncology News

Oncology Video Recap—February 2, 2026

This biweekly video recap in oncology summarizes regulatory actions, late-stage…

by Ruairi McEntee

Onco_background

Oncology Today—February 2, 2026

This weekly update in oncology covers regulatory actions, clinical progress,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Oncology Video Recap—February 2, 2026
Oncology Today—February 2, 2026
Hematology Today—February 2, 2026
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission

Tags

AHA 2025 AI in Aesthetics Amycretin Antengene AtriCure Biorep Technologies blood biomarkers BMJ cancer CB1 pathway Central nervous system diseases Chronic disease management Clinical Decision-Making CONMED Datroway Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals Fenfluramine G6PD deficiency Harbour BioMed Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors PD-1 combinations pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Samsung Bioepis scientific computing Sema4 Thermo Fisher

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Oncology Video Recap—February 2, 2026
Oncology Today—February 2, 2026
Hematology Today—February 2, 2026
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission

TAGS

AHA 2025 AI in Aesthetics Amycretin Antengene AtriCure Biorep Technologies blood biomarkers BMJ cancer CB1 pathway Central nervous system diseases Chronic disease management Clinical Decision-Making CONMED Datroway Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals Fenfluramine G6PD deficiency Harbour BioMed Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors PD-1 combinations pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Samsung Bioepis scientific computing Sema4 Thermo Fisher

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy